NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.”

DEA 162

DEA Research and Development Clinical Trials Marijuana 162

Cannabis Law Report

JUNE 24, 2022

The leader of the New Jersey Senate filed a bill on Thursday that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older—with provisions that give adults even more freedoms for the psychedelic than are afforded under the state’s current marijuana laws. Marijuana Moment reports.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. However, MMJ cultivation is subject to strict regulations and oversight by state authorities to ensure compliance with the law.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

SEPTEMBER 12, 2022

All Optimi mushroom products are grown from the Company’s world-leading psilocybin genetic bank and are grown in EU-GMP compliant clean rooms that ensure sterile cultivation and undergo almost 300 different analytical tests post-harvest. “Our To access a complete photo gallery of this historic grow, please click here. Penis Envy.

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

CannaMD

APRIL 23, 2020

For those unfamiliar, GB Sciences is a technology company that merges plant biology, cultivation, and post-production processes in order to optimize safe, consistent medical cannabis treatment. They describe their goal as “marrying cutting edge cannabis cultivation with biopharmaceutical research and development.”

Clinical Trials 116

Clinical Trials Research and Development Marijuana Treatment 116

Cannabis Law Report

FEBRUARY 3, 2022

Together with its wide network of research partners, MediCane is executing clinical programs to develop cannabis-based drugs with two leading therapeutic areas – Behavioral and Psychological Symptoms of Dementia (BPSD) and sleep disorders. The company launched its manufacturing facility in Kfar Saba in 2020.

Clinical Trials 52

Clinical Trials Research and Development Packaging Oil 52

Cannabis Law Report

JUNE 11, 2021

Over the past months, Mydecine’s research and development teams have screened over 25 mushroom species, including various varieties of p. We have seen accelerated progress through Mydecine’s fully integrated research and cultivation facilities,” stated Josh Bartch, CEO of Mydecine. About Mydecine Innovations Group.

Research and Development 59

Research and Development Clinical Trials Therapy Pharmaceutical 59

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Rick Doblin founded MAPS as an official 501(c)(3) non-profit research organization on April 8, 1986. Members of Congress voiced support for marijuana/AIDS research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

MARCH 3, 2022

Vincent and the Grenadines (SVG) is looking to position itself as one of the most progressive countries on the planet for psychedelic research. . If everything works out in the production and research phase, there is a clause in the license that will allow it to be expanded to clinical trials. and Europe.

Research and Development 52

Research and Development Medicine Clinical Trials Microdosing 52

Cannabis Law Report

NOVEMBER 13, 2019

Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. We gave the option to foreign companies to cultivate in Denmark.”. The roadmap ahead includes clinical trials and more research in Denmark. Founder and CEO,

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

SpeedWeed

AUGUST 4, 2021

Medical Cannabis Australia, the company she founded, just obtained its cultivation and manufacture licenses from the Office of Drug Control (ODC) in April of this year. This event saw doctors and researchers from all over the world presenting the scientific and clinical studies surrounding the medical benefits of cannabis. .

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

OCTOBER 3, 2019

Cannabis was high on the regulatory agenda in September, with two significant developments: 1. The Australian Capital Territory ( ACT ) voted to legalise the personal possession and cultivation of cannabis. The ACT Legislative Assembly voted to legalise the personal possession and cultivation of cannabis on 25 September 2019.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

Cannabis Law Report

OCTOBER 26, 2019

ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). One such circumstance is a clinical trial. medical practitioner), an organisation (e.g.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

JUNE 9, 2022

The bill aims to improve the quality of medical services for the population that undergoes palliative medicine and encourage medical research on cannabis. In the Law of Ukraine “On Narcotic Drugs, Psychotropic Substances and Precursors” (Vidomosti Verkhovnoi Rady Ukrainy, 1995, ?

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

JANUARY 18, 2019

Alvit LCS Pharma was founded in 2014 with the goal of researching and developing cannabis-based pharmaceutical products that speak the language of doctors. Since then, the company has successfully developed a broad line of pharma grade cannabis products that include various types of tablets, sprays, suppositories, and more.

Research and Development 40

Research and Development Clinical Trials Extraction Therapy 40

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

APRIL 10, 2019

These include “to initiate a process evaluation to address barriers” and to ask “the National Institute for Health Research and the industry to take action to produce … evidence in a form that will support decisions about public funding.”. I did set out the answers to those questions in my initial response.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

SMPL

MAY 26, 2020

Near him was Stacey Kerr, a physician with flowing silver hair who served as treasurer of the Society of Cannabis Clinicians, as well as Wade Laughter, a soft-spoken man in glasses who had started cultivating pot for his glaucoma in the mid-90s. Both pledged to keep their strains available for other growers at cheap prices.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. Michigan’s Department of Agriculture and Rural Development announced the implementation of testing standards for the state’s first crop of industrial hemp.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

JULY 15, 2022

The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. “We cultivate, we produce, we manufacture, we bottle and then we distribute onsite, which I think for accountability is very important.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. CBD candles and outdoor grow lights for home cultivation) are expected to embrace cannabis to various degrees.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

FEBRUARY 28, 2020

It took twelve months of research, investigations and interviews (and about five weeks of non-stop writing with some very late nights and a lot of coffee) to produce my book on cannabis law and regulation, which is out now with Bloomsbury Professional. Friends of the people. The story is remarkably different at domestic level.

Law 59

Law Research and Development Recreational Cannabis 59